Results 51 to 60 of about 239,540 (278)

Organoids in pediatric cancer research

open access: yesFEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

[18F]-(2S,4R)4-Fluoroglutamine PET Imaging of Glutamine Metabolism in Murine Models of Hepatocellular Carcinoma (HCC)

open access: yesMolecular Imaging, 2022
Purpose. Quantitative in vivo [18F]-(2S,4R)4-fluoroglutamine ([18F]4-FGln or more simply [18F]FGln) metabolic kinetic parameters are compared with activity levels of glutamine metabolism in different types of hepatocellular carcinoma (HCC). Methods.
Youngho Seo   +5 more
doaj   +1 more source

Sirtuin functions and modulation: from chemistry to the clinic [PDF]

open access: yes, 2016
Sirtuins are NAD+ -dependent histone deacetylases regulating important metabolic pathways in prokaryotes and eukaryotes and are involved in many biological processes such as cell survival, senescence, proliferation, apoptosis, DNA repair, cell ...
Altucci, Lucia   +9 more
core   +2 more sources

Interplay between circadian and other transcription factors—Implications for cycling transcriptome reprogramming

open access: yesFEBS Letters, EarlyView.
This perspective highlights emerging insights into how the circadian transcription factor CLOCK:BMAL1 regulates chromatin architecture, cooperates with other transcription factors, and coordinates enhancer dynamics. We propose an updated framework for how circadian transcription factors operate within dynamic and multifactorial chromatin landscapes ...
Xinyu Y. Nie, Jerome S. Menet
wiley   +1 more source

MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity

open access: yeseLife, 2020
Metastasis is a major cause of cancer mortality. We generated an autochthonous transgenic mouse model whereby conditional expression of MYC and Twist1 enables hepatocellular carcinoma (HCC) to metastasize in >90% of mice.
Renumathy Dhanasekaran   +17 more
doaj   +1 more source

NDRG1 (N-myc downstream regulated 1) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2018
Review on NDRG1 (N-myc downstream regulated 1)
Nagai, Maria A, Mangone, Flavia R
openaire   +2 more sources

The impact of N-myc amplification on median survival in children with neuroblastoma [PDF]

open access: yes, 2013
Background: Neuroblastoma is the most common extracranial malignant solid tumor in children under 5 years, and it is characterized by wide clinical and biological heterogeneity.
Azizi Malamiri, Reza.   +5 more
core  

Regulation of N-Myc downstream regulated gene 2 by bile acids [PDF]

open access: yes, 2017
Here we report that bile acid chenodeoxycholic acid (CDCA) and synthetic farnesoid X receptor (FXR) agonist GW4064 robustly induced tumor suppressor N-Myc downstream regulated gene 2 (NDRG2) expression in human hepatoma cells and primary hepatocytes ...
Donate, Yolanda   +5 more
core   +1 more source

Protein pyrophosphorylation by inositol pyrophosphates — detection, function, and regulation

open access: yesFEBS Letters, EarlyView.
Protein pyrophosphorylation is an unusual signaling mechanism that was discovered two decades ago. It can be driven by inositol pyrophosphate messengers and influences various cellular processes. Herein, we summarize the research progress and challenges of this field, covering pathways found to be regulated by this posttranslational modification as ...
Sarah Lampe   +3 more
wiley   +1 more source

Anti-c-myc cholesterol based lipoplexes as onco-nanotherapeutic agents in vitro [version 2; peer review: 3 approved]

open access: yesF1000Research, 2021
Background: Strategies aimed at inhibiting the expression of the c-myc oncogene could provide the basis for alternative cancer treatment. In this regard, silencing c-myc expression using small interfering RNA (siRNA) is an attractive option. However, the
Saffiya Habib   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy